Global Ingestible Temperature Sensor Supply, Demand and Key Producers, 2026-2032
Description
The global Ingestible Temperature Sensor market size is expected to reach $ 51.71 million by 2032, rising at a market growth of 9.3% CAGR during the forecast period (2026-2032).
Ingestible Temperature Sensor is a disruptive technology in disease diagnostics, monitoring, and management. In simple terms, they are ingestible electronic devices, roughly the size of a medicine capsule, composed of biocompatible materials that make up a power supply, microprocessor, controller, sensors, etc., giving the device the ability to telecommunicate for use in the healthcare industry for disease diagnostics and monitoring.By 2024, global sales of ingestible temperature sensors will reach 640,000 units, with an average selling price of US$40 per unit. The industry's gross profit margin is expected to be approximately 40%.
The world top players in the Ingestible Temperature Sensor market are Koninklijke Philips, HQ, Medtronic, BodyCap, myTemp BV and so on. These top companies currently account for more than 87% of the total market share and are expected to retain their dominating hold over the market during the forecast period.
Market drivers primarily include the following:
Evolving clinical needs and the trend toward personalized medicine
Traditional temperature measurement methods (such as oral and rectal temperature measurement) are highly invasive and have limited data continuity. Ingestible sensors, however, offer 24-hour non-invasive monitoring, making them particularly suitable for critically ill patients, those recovering from surgery, and in sports medicine. For example, athletes can use long-term temperature data to optimize their training plans and avoid the health risks associated with excessive fatigue. Furthermore, with the increasing adoption of precision medicine, doctors can adjust treatment plans (such as chemotherapy drug dosages) based on real-time temperature fluctuations, improving treatment effectiveness.
Technological breakthroughs lower barriers to entry
Recent advances in flexible electronics, microbatteries, and wireless communication technologies have significantly improved sensor performance. For example, sensors made of biodegradable polymer materials can naturally decompose within the body, eliminating the need for secondary surgical removal. Low-power chip designs extend device battery life to over seven days, meeting long-term monitoring needs. Furthermore, the introduction of artificial intelligence algorithms can automatically analyze temperature data, identify abnormal patterns (such as low-grade fever at night), and assist doctors in rapid diagnosis.
Policy support and an influx of capital are accelerating commercialization.
Governments around the world have prioritized ingestible sensors as a key area of medical innovation, promoting their implementation through initiatives such as approval pathways and R&D subsidies. For example, the US FDA launched the "Digital Health Pre-certification Program" to streamline the approval process for innovative medical devices; the China National Medical Products Administration issued the "Technical Guidelines for Clinical Evaluation of Ingestible Electronic Devices," clarifying product safety and effectiveness standards. Furthermore, venture capital firms are increasing their support for startups, with global funding for ingestible sensor technology expected to increase by 40% year-over-year in 2024, with the funds primarily used for capacity expansion and clinical trials.
This report studies the global Ingestible Temperature Sensor production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Ingestible Temperature Sensor and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Ingestible Temperature Sensor that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Ingestible Temperature Sensor total production and demand, 2021-2032, (Units)
Global Ingestible Temperature Sensor total production value, 2021-2032, (USD Million)
Global Ingestible Temperature Sensor production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (Units), (based on production site)
Global Ingestible Temperature Sensor consumption by region & country, CAGR, 2021-2032 & (Units)
U.S. VS China: Ingestible Temperature Sensor domestic production, consumption, key domestic manufacturers and share
Global Ingestible Temperature Sensor production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (Units)
Global Ingestible Temperature Sensor production by Type, production, value, CAGR, 2021-2032, (USD Million) & (Units)
Global Ingestible Temperature Sensor production by Application, production, value, CAGR, 2021-2032, (USD Million) & (Units)
This report profiles key players in the global Ingestible Temperature Sensor market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Koninklijke Philips, HQ, Medtronic, BodyCap, myTemp BV, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Ingestible Temperature Sensor market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Ingestible Temperature Sensor Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World
Global Ingestible Temperature Sensor Market, Segmentation by Type:
Up to 48 Hour Period
Above 48 Hour Period
Global Ingestible Temperature Sensor Market, Segmentation by Application:
Healthcare/Medical
Sport & Fitness
Other
Companies Profiled:
Koninklijke Philips
HQ
Medtronic
BodyCap
myTemp BV
Key Questions Answered:
1. How big is the global Ingestible Temperature Sensor market?
2. What is the demand of the global Ingestible Temperature Sensor market?
3. What is the year over year growth of the global Ingestible Temperature Sensor market?
4. What is the production and production value of the global Ingestible Temperature Sensor market?
5. Who are the key producers in the global Ingestible Temperature Sensor market?
6. What are the growth factors driving the market demand?
Ingestible Temperature Sensor is a disruptive technology in disease diagnostics, monitoring, and management. In simple terms, they are ingestible electronic devices, roughly the size of a medicine capsule, composed of biocompatible materials that make up a power supply, microprocessor, controller, sensors, etc., giving the device the ability to telecommunicate for use in the healthcare industry for disease diagnostics and monitoring.By 2024, global sales of ingestible temperature sensors will reach 640,000 units, with an average selling price of US$40 per unit. The industry's gross profit margin is expected to be approximately 40%.
The world top players in the Ingestible Temperature Sensor market are Koninklijke Philips, HQ, Medtronic, BodyCap, myTemp BV and so on. These top companies currently account for more than 87% of the total market share and are expected to retain their dominating hold over the market during the forecast period.
Market drivers primarily include the following:
Evolving clinical needs and the trend toward personalized medicine
Traditional temperature measurement methods (such as oral and rectal temperature measurement) are highly invasive and have limited data continuity. Ingestible sensors, however, offer 24-hour non-invasive monitoring, making them particularly suitable for critically ill patients, those recovering from surgery, and in sports medicine. For example, athletes can use long-term temperature data to optimize their training plans and avoid the health risks associated with excessive fatigue. Furthermore, with the increasing adoption of precision medicine, doctors can adjust treatment plans (such as chemotherapy drug dosages) based on real-time temperature fluctuations, improving treatment effectiveness.
Technological breakthroughs lower barriers to entry
Recent advances in flexible electronics, microbatteries, and wireless communication technologies have significantly improved sensor performance. For example, sensors made of biodegradable polymer materials can naturally decompose within the body, eliminating the need for secondary surgical removal. Low-power chip designs extend device battery life to over seven days, meeting long-term monitoring needs. Furthermore, the introduction of artificial intelligence algorithms can automatically analyze temperature data, identify abnormal patterns (such as low-grade fever at night), and assist doctors in rapid diagnosis.
Policy support and an influx of capital are accelerating commercialization.
Governments around the world have prioritized ingestible sensors as a key area of medical innovation, promoting their implementation through initiatives such as approval pathways and R&D subsidies. For example, the US FDA launched the "Digital Health Pre-certification Program" to streamline the approval process for innovative medical devices; the China National Medical Products Administration issued the "Technical Guidelines for Clinical Evaluation of Ingestible Electronic Devices," clarifying product safety and effectiveness standards. Furthermore, venture capital firms are increasing their support for startups, with global funding for ingestible sensor technology expected to increase by 40% year-over-year in 2024, with the funds primarily used for capacity expansion and clinical trials.
This report studies the global Ingestible Temperature Sensor production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Ingestible Temperature Sensor and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Ingestible Temperature Sensor that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Ingestible Temperature Sensor total production and demand, 2021-2032, (Units)
Global Ingestible Temperature Sensor total production value, 2021-2032, (USD Million)
Global Ingestible Temperature Sensor production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (Units), (based on production site)
Global Ingestible Temperature Sensor consumption by region & country, CAGR, 2021-2032 & (Units)
U.S. VS China: Ingestible Temperature Sensor domestic production, consumption, key domestic manufacturers and share
Global Ingestible Temperature Sensor production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (Units)
Global Ingestible Temperature Sensor production by Type, production, value, CAGR, 2021-2032, (USD Million) & (Units)
Global Ingestible Temperature Sensor production by Application, production, value, CAGR, 2021-2032, (USD Million) & (Units)
This report profiles key players in the global Ingestible Temperature Sensor market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Koninklijke Philips, HQ, Medtronic, BodyCap, myTemp BV, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Ingestible Temperature Sensor market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Ingestible Temperature Sensor Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World
Global Ingestible Temperature Sensor Market, Segmentation by Type:
Up to 48 Hour Period
Above 48 Hour Period
Global Ingestible Temperature Sensor Market, Segmentation by Application:
Healthcare/Medical
Sport & Fitness
Other
Companies Profiled:
Koninklijke Philips
HQ
Medtronic
BodyCap
myTemp BV
Key Questions Answered:
1. How big is the global Ingestible Temperature Sensor market?
2. What is the demand of the global Ingestible Temperature Sensor market?
3. What is the year over year growth of the global Ingestible Temperature Sensor market?
4. What is the production and production value of the global Ingestible Temperature Sensor market?
5. Who are the key producers in the global Ingestible Temperature Sensor market?
6. What are the growth factors driving the market demand?
Table of Contents
94 Pages
- 1 Supply Summary
- 2 Demand Summary
- 3 World Manufacturers Competitive Analysis
- 4 United States VS China VS Rest of the World
- 5 Market Analysis by Type
- 6 Market Analysis by Application
- 7 Company Profiles
- 8 Industry Chain Analysis
- 9 Research Findings and Conclusion
- 10 Appendix
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
